| abstract |
The main object of the present invention is to provide a novel compound having VEGF receptor tyrosine kinase inhibitory activity and useful as a therapeutic drug for diseases accompanied by angiogenesis or edema, such as age-related macular degeneration. Examples of the present invention include alkynylindazole derivatives represented by the following general formula (I) or pharmaceutically acceptable salts thereof, and pharmaceuticals containing these compounds. (In the formula, each symbol is as described in the description.) The above-mentioned alkynylindazole derivatives and the like can be used in the form of liquid preparations such as eye drops and injections, for example. |